| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2023 | Mar 2, 2023 | Vir Biotechnology, Inc. | Director | Buy | 95.0 | +2,500 | 14.47% | ✓ | $56.8K |
| Jan 5, 2023 | Jan 9, 2023 | Vir Biotechnology, Inc. | Director | Buy | 95.0 | +2,500 | 16.92% | ✓ | $62.4K |
| Jan 3, 2023 | Jan 5, 2023 | Vir Biotechnology, Inc. | Director | Buy | 95.0 | +5,000 | 51.13% | ✓ | $127.1K |
| May 19, 2016 | May 19, 2016 | Adaptimmune Therapeutics PLC | Director | Buy | 83.8 | +15,000 | 4.26% | ✗ | $23.4K |
| May 16, 2016 | May 18, 2016 | Adaptimmune Therapeutics PLC | Director | Buy | 95.0 | +45,000 | 14.66% | ✗ | $68.7K |